These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9160913)

  • 1. Second harmonic characteristics of the ultrasound contrast agents albunex and FSO69.
    Krishna PD; Newhouse VL
    Ultrasound Med Biol; 1997; 23(3):453-9. PubMed ID: 9160913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative measurements of second harmonic Doppler using ultrasound contrast agents.
    Chang PH; Shung KK; Levene HB
    Ultrasound Med Biol; 1996; 22(9):1205-14. PubMed ID: 9123645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement.
    Shankar PM; Dala Krishna P; Newhouse VL
    Ultrasound Med Biol; 1998 Mar; 24(3):395-9. PubMed ID: 9587994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset delay of acoustic second harmonic backscatter from bubbles or microspheres.
    Zheng W; Newhouse VL
    Ultrasound Med Biol; 1998 May; 24(4):513-22. PubMed ID: 9651961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging.
    Colon PJ; Richards DR; Moreno CA; Murgo JP; Cheirif J
    J Am Soc Echocardiogr; 1997; 10(6):602-7. PubMed ID: 9282349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subharmonic generation from ultrasonic contrast agents.
    Krishna PD; Shankar PM; Newhouse VL
    Phys Med Biol; 1999 Mar; 44(3):681-94. PubMed ID: 10211802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonic characterization of the nonlinear properties of contrast microbubbles.
    Shi WT; Forsberg F
    Ultrasound Med Biol; 2000 Jan; 26(1):93-104. PubMed ID: 10687797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and spectrum analysis of contrast agents in the in vivo rabbit eye using very-high-frequency ultrasound.
    Deng CX; Lizzi FL; Silverman RH; Ursea R; Coleman DJ
    Ultrasound Med Biol; 1998 Mar; 24(3):383-94. PubMed ID: 9587993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations.
    Miller MW; Everbach EC; Cox C; Knapp RR; Brayman AA; Sherman TA
    Ultrasound Med Biol; 2001 May; 27(5):709-21. PubMed ID: 11397535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of scattered subharmonic, 3.3-MHz fundamental and second harmonic signals to damage of monolayer cells by ultrasonically activated Albunex.
    Miller DL; Bao S
    J Acoust Soc Am; 1998 Feb; 103(2):1183-9. PubMed ID: 9479770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subharmonic imaging of contrast agents.
    Forsberg F; Shi WT; Goldberg BB
    Ultrasonics; 2000 Mar; 38(1-8):93-8. PubMed ID: 10829636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
    Hasegawa M; Saiki Y; Kayano H; Katagiri T
    Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subharmonic signal generation from contrast agents in simulated neovessels.
    Bhagavatheeshwaran G; Shi WT; Forsberg F; Shankar PM
    Ultrasound Med Biol; 2004 Feb; 30(2):199-203. PubMed ID: 14998672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
    Bleeker H; Shung K; Barnhart J
    J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrasound scattering properties of Albunex microspheres].
    Takamoto T; Shiina T
    Nihon Rinsho; 1998 Apr; 56(4):871-5. PubMed ID: 9577600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents.
    Miller DL; Gies RA
    Ultrasound Med Biol; 1998 Feb; 24(2):285-92. PubMed ID: 9550187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging.
    Hancock J; Dittrich H; Jewitt DE; Monaghan MJ
    Heart; 1999 Jun; 81(6):636-41. PubMed ID: 10336924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection procedures of ultrasound contrast agents.
    de Jong N; Frinking PJ; Bouakaz A; Ten Cate FJ
    Ultrasonics; 2000 Mar; 38(1-8):87-92. PubMed ID: 10829635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin.
    Porter TR; Xie F; Kricsfeld D; Armbruster RW
    J Am Coll Cardiol; 1996 May; 27(6):1497-501. PubMed ID: 8626965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.